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A quantitative analysis of the pathways leading to glycogen repletion in rats was conducted. [U-‘3C]Glucose 
was administered intra-intestinally into awake fasted animals. The distribution of glucose isotopomers de- 
rived from liver glycogen, liver extracts and plasma was performed by GC-MS and 13C NMR. The potential 
gluconeogenic precursors for liver glycogen, lactate, alanine, glutamate and glutamine, were also analyzed. 
The amount of glycogen that is synthesized by the direct pathway was found to be 35%. The 13C enrichment 
of liver lactate, alanine and glucose is similar, indicating that they are the major precursors for liver glycogen 
synthesis via the indirect pathway. Our results demonstrate that after 24 h fasting, when glucose is supplied, 
gluconeogenesis from endogenous sources is not shut off. 
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1. INTRODUCTION 
The conventional concept that glucose serves as 
the major substrate and a direct precursor of liver 
glycogen (glucose - glucose 6-P - glycogen) 
has recently been questioned [11. Ultimately, it has 
been suggested that liver glycogen is formed main- 
ly by an indirect pathway from C3 compounds 
[2-61 (glucose - pyruvate - glucose 6-P --) 
glycogen). So far, quantitative analyses of the 
main routes leading to glycogen repletion are 
scarce. 
In this study a quantitative analysis of the 
pathways leading to glycogen repletion was per- 
formed, using stable isotope techniques. 13C label- 
ling pattern and distribution of glucose 
isotopomers (13Cg; 13C5, “C,; 13Cq, “C2; etc.) 
derived from liver glycogen, liver extracts and 
plasma were determined by 13C NMR and gas 
chromatography mass-spectrometry (GC-MS). 
13C-labelled metabolites, lactate, alanine, 
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glutamate and glutamine, considered the potential 
gluconeogenic precursors for liver glycogen reple- 
tion, via the indirect route, were also observed by 
13C NMR and quantitatively analyzed by GC-MS. 
Detailed accounts will be published elsewhere. 
2. MATERIALS AND METHODS 
2.1. Materials 
[U-‘3C]Glucose (98% enriched) was prepared in 
our laboratory from 13C02 (98% enriched) [7]. 
2.2. Animals 
Rats (weighing 180-240 g), surgically fitted with 
a silastic tube inserted into the intestinal lumen, 
were placed in restraining cages. A solution of 
[U-‘3C]glucose (98% enriched, diluted with 
unlabelled glucose to 36% enrichment), was in- 
fused intra-intestinally for 2 h, into awake, 24 h 
fasted animals (80 mg/lOO g body wt per h). At 
the end of the infusion the rats were anesthetized, 
portal venous blood taken, and the livers quickly 
removed and frozen in liquid Nz. Liver glycogen 
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was separated and samples used for various 
#determinations. 
2.3. 13C NMR measurements 
13C NMR measurements were performed on a 
chemical ionization (CI) mode with isobutane as 
reactant gas. Samples were injected through the 
W-MS inlet system. Measurements of isotopic 
abundance were made using computer-selected ion 
monitoring (SIM). 
Bruker AM-400 MHz Fourier transform spec- 
trometer operating at 100.614 MHz. Proton- 
broad-band decoupled 13C NMR spectra were ob- 
tained in the following spectrometer conditions: 
80” pulses, 23.8 kHz spectral width, 16K Fourier 
data transformation and 2380 accumulations. To 
reduce effects from dielectric heating and to main- 
tain the sample temperature at about 20°C, power- 
gated proton decoupling was used. 
Glucose samples derived from liver glycogen, 
liver extracts and plasma were analyzed as the 
trimethylsilyl derivatives, amino acids as 
trifluoroacetyl n-butyl esters and lactate was 
derivatized to n-propylamide n-heptafluoro- 
butyrate. The distribution of the isotopomers and 
atom% enrichment were determined as previously 
described [8]. 
2.4. GC-MS 
3. RESULTS AND DISCUSSION 
GC-MS analyses were performed on a Finnigan 3.1. 13C NMR spectroscopy 
4500 quadrupole GC-MS interfaced to an INCOS 13C NMR resolved signals from enriched 13C in- 
data system. The mass spectrometer was operated tracellular metabolites of liver extract are depicted 
in the electron impact (EI) mode, or in the in fig.1. The spectrum consists of numerous 
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Fig.1. 100.614 MHz ‘k NMR spectrum of rat liver extract (free of glycogen). 
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resonances that have been assigned to glucose, lac- 
tate, alanine, glutamate and glutamine, indicating 
that they are the main glucose metabolites which 
are the immediate glycogen precursors. The 
multiplets observed in the 13C NMR spectrum are 
due to the existence of high percentage of 13C 
isotopomers having adjacent 13C atoms in the same 
molecule. Since [U-13C]glucose was diluted with 
unlabelled glucose, it demonstrates that the 
glucose metabolites are mainly non-recycled. 
These results are in accordance with the GC-MS 
results. 
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3.2. GC-MS measurements 
[U-13C]Glucose (98% labelled) was diluted by 
non-labelled glucose in order to minimize the 
probability of two labelled three-carbon in- 
termediates joining together to form a glucose 
molecule. The 13C enrichments of infused glucose 
(36.1 atom%) and of portal vein plasma, liver ex- 
tract and liver glycogen were determined by CI 
GC-MS measurements and are summarized in 
table l(a). In various compartments the fraction of 
isotopomers (P,) containing n 13C atoms varied as 
a function of glucose recycling. R is the ratio of 
glucose molecules having six 13C atoms over the 
sum of the labelled isotopomer molecules. R values 
as a function of [U-13C]glucose dilution are 
depicted in fig.2. A significant decrease of R as a 
function of increased dilutions of the infused 
[U-13C]glucose was obtained for glucose derived 
from different body compartments. R, (obtained 
at infinite dilution) for glucose of the different 
Fig.2. R values (see text) of glucose from different 
origins as a function of [U-“Clglucose dilutions: 
glycogen-glucose (A), liver extract (0) and portal vein 
plasma (0). 
origins represents the non-recycled glucose. The 
R, values obtained were 57% for the portal vein 
plasma glucose, 20.5% for liver glycogen glucose 
and 23.5% for liver extract glucose. The non- 
significant difference of R, values of liver 
glycogen and liver extract glucoses enabled us to 
consider the liver glucose isotopomer distribution 
as reflecting the liver glycogen glucose isotopomer 
composition. The ratio of R, values of liver 
glycogen glucose and of portal vein glucose is 
35070, indicating that only one third of the plasma 
[U-13C]glucose contributes to the synthesis of 
glycogen via the direct pathway. From the ratio of 
R,(portal vein)/R,(infused material), it was found 
Table 1 
r3C enrichment and isotopomer distribution, calculated from chemical ionization 
(CI) mass spectra, of glucose in various compartments (a), and 13C enrichment of 
glycogen and of gluconeogenic precursors in liver extracts (b) 
(a) 13C enrichment I5 Pn R 
(atom% excess) ?I=1 
Infused glucose 36.1 36.8 89.4 
Portal vein glucose 28.3 34.0 68.5 
Liver glucose 21.0 33.9 35.3 
Liver glycogen glucose 8.2 13.6 34.5 
(b) Lactate Alanine Glutamate Aspartate Glucose Glycogen 
Liver 16.5 + 0.5 16.2 + 0.8 3.3 f 0.55 5.0 + 0.8 21.4 + 0.9 8.1 
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that 63% of the plasma glucose is derived directly 
from the intact molecules of infused 
[U-‘3C]glucose, the other 37% of the plasma 
glucose (and consequently hepatic glycogen) being 
recycled through glycolysis and gluconeogenesis. 
The data summarized in table l(b) were derived 
from CI GC-MS measurements. A very important 
datum is deduced from the 13C enrichments found 
for lactate or alanine in comparison to hepatic 
glucose. The calculated 13C enrichment, cor- 
responding to the indirect pathway of liver glucose 
synthesis, is found to be 16% which is very similar 
to the enrichment found for lactate or alanine, 
supporting our 13C NMR results that they are the 
major source for glucose synthesis via 
gluconeogenesis. The lower r3C enrichment of 
glycogen-glucose is a result of pre-steady state 
glucogen synthesis conditions (further studies are 
to be published). 
In conclusion, the design of the present study 
enabled us to quantitate the metabolic pathways 
leading to glycogen repletion after [U-13C]glucose 
infusion, from the isotopomer distribution of the 
labelled glucose molecules employing CI GC-MS 
methodology which avoids separation and 
degradation methods needed for radioisotope 
techniques [l-5]. (i) Only 35% of liver glycogen 
repletion originates from the direct conversion of 
glucose into glycogen. (ii) The other two-thirds of 
the glycogen repletion occurs via the indirect 
pathway, i.e. conversion of glucose to three- 
carbon units, mainly lactate and alanine and subse- 
quently via glucose 6-P to glycogen. This is the 
first quantitative demonstration that lactate 
and/or alanine are the main precursors for the in- 
direct route of glycogen repletion. (iii) Our results 
indicate that even when glucose is supplied after 
24 h fasting, gluconeogenesis from endogenous 
sources is not shut off. The newly synthesized 
glucose is mainly directed into liver glycogen, but 
the liver glucose production is not completely 
suppressed. 
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